Scilex Holding Co. (SCLX)
2.82
-0.03
(-1.05%)
USD |
NASDAQ |
Oct 15, 16:00
2.87
+0.05
(+1.77%)
After-Hours: 20:00
Scilex Profit Margin (Quarterly) : -1.52K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.52K% |
| March 31, 2026 | -530.0% |
| December 31, 2025 | -961.9% |
| September 30, 2025 | -2.44K% |
| June 30, 2025 | -887.2% |
| March 31, 2025 | -521.2% |
| December 31, 2024 | -43.36% |
| September 30, 2024 | -30.40% |
| June 30, 2024 | -229.6% |
| Date | Value |
|---|---|
| March 31, 2024 | -224.0% |
| December 31, 2023 | -159.0% |
| September 30, 2023 | -351.2% |
| June 30, 2023 | -211.8% |
| March 31, 2023 | -290.6% |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -225.1% |
| March 31, 2022 | -134.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 0.83% |
| Eli Lilly & Co. | 30.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -183.1% |
| Gross Profit Margin (Quarterly) | 14.73% |
| Operating Margin (Quarterly) | -385.0% |
| Return on Net Operating Assets | -334.0% |